Functional outcome following rehabilitation of the cancer patient

被引:110
作者
Marciniak, CM [1 ]
Sliwa, JA [1 ]
Spill, G [1 ]
Heinemann, AW [1 ]
Semik, PE [1 ]
机构
[1] NORTHWESTERN UNIV,SCH MED,DEPT PHYS MED & REHABIL,CHICAGO,IL
来源
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION | 1996年 / 77卷 / 01期
关键词
D O I
10.1016/S0003-9993(96)90220-8
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To identify impairments resulting from cancer or its treatment in patients undergoing inpatient rehabilitation, to assess the extent of functional gains, and to determine if cancer type, ongoing radiation treatment, or the presence of metastatic disease influences functional improvement. Design and Setting: A retrospective, case series of cancer patients undergoing inpatient rehabilitation at a free-standing, university-affilitated rehabilitation hospital. Participants: A referred sample of 159 patients admitted because of functional impairments resulting from cancer or its treatment during a 2-year time period. Intervention: Comprehensive inpatient rehabilitation. Main Outcome Measure: Functional status as measured by the motor score of the Functional Independence Measure. Results: Significant functional gains were made between admission (mean = 42.9) and discharge (mean = 56.0; p < .001), with all cancer subgroups making similar gains. The presence of metastatic disease did not influence functional outcome, and those patients receiving radiation actually made larger functional improvement (p = .025). Conclusion: Individuals impaired by cancer or its treatment benefit from inpatient rehabilitation. The presence of metastatic disease or ongoing radiation should not preclude participation. (C) 1996 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation
引用
收藏
页码:54 / 57
页数:4
相关论文
共 18 条
[1]  
[Anonymous], 1987, REHABILITATION OUTCO
[2]  
Brennan M J, 1993, J Back Musculoskelet Rehabil, V3, P1, DOI 10.3233/BMR-1993-3204
[3]  
CLARK RL, 1967, CANCER-AM CANCER SOC, V20, P839, DOI 10.1002/1097-0142(1967)20:5<839::AID-CNCR2820200542>3.0.CO
[4]  
2-8
[5]  
DIETZ JH, 1969, MED CLIN N AM, V53, P607
[6]  
FORER SK, 1980, ARCH PHYS MED REHAB, V61, P359
[7]  
GAMBLE GL, 1990, ARCH PHYS MED REHAB, V71, pS244
[8]   NERVOUS-SYSTEM TOXIC EFFECTS OF CANCER-THERAPY [J].
GOLDBERG, ID ;
BLOOMER, WD ;
DAWSON, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (10) :1437-1441
[9]  
GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133
[10]  
GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870